Atlas Trials

A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma

Clinical trial NCT02820584 · COMPLETED

Trial details

NCT number
NCT02820584
Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
de Novo Glioblastoma
Start date
2016-09-01
Primary completion
2017-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.